A higher CD4+/CD8+ ratio correlated with better clinical status in the acute and subacute phases of stroke, suggesting a detrimental effect of CD8+ T cells and a beneficial effect of CD4+ T cells already at the early stage of ischemia. The gene discussed is CD8A; the disease is ischemia.